GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...

Create a list of the investments you want to track.

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Health ...

11th Apr 2025 7:00 am RNS Transaction in Own Shares 10th Apr 2025 7:00 am RNS Transaction in Own Shares 9th Apr 2025 7:00 am RNS Transaction in Own Shares 8th Apr ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc. a global biopharma company to unite science technology and talent to get ahead of disease together. The Company is ...

At close: April 9 at 4:00:02 PM EDT ...